01692cam a22001818i 4500020001800000041000900018082001700027100002900044245008400073250001900157260003600176300001800212504005100230520115700281546001301438650003601451650002301487  a9789391165321  aeng.00a615.1bEBA-B1 aEban, Katherineeauthor.10aBottle of lies :bRanbaxy and the dark side of Indian Pharma /cKatherine Eban.  aFirst edition.  aNew Delhi :bJuggernaut,c2019.  axxviii, 482p.  aIncludes bibliographical references and index.  aIn 2004, Dinesh Thakur, a senior employee of Ranbaxy, then India’s largest pharma company, discovered a terrible secret.Ranbaxy had been fabricating the test results of their drugs,endangering millions of patients. Thakur resigned and became a whistleblower to the US Food and Drug Administration, one of the regulators Ranbaxy had been lying to, and ultimately brought the multibillion-dollar behemoth to its knees. This is the sensational account of the high-stakes chase to bring Ranbaxy to book and the fall from grace of one of corporate India’s biggest success stories. But the rot in Indian pharma isn’t confined to Ranbaxy alone. In this book, investigative journalist Katherine Eban relies on over 20,000 FDA documents and interviews with over 240 people to show how fraud and trickery are deeply entrenched in much of the industry in India, and raises troubling questions about some of its biggest names – Wockhardt, Dr Reddy’s, Glenmark and RPG Life Sciences. Filled with shocking and eye-opening details, this book lays bare the ugly truth of Indian pharma. It will make you view every pill you take with foreboding and suspicion.  aEnglish. 0aGeneric drugsxQuality control. 0aDrug adulteration.